-
Hepatol Int | 24-Hour Comprehensive Lifestyle Interventions Help Prevent and Control MAFLD
Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common liver disease worldwide, with recent data showing prevalence rates of up to 39% in adults and 20% in children. MAFLD is characterized by overweight or obesity, type 2 diabetes, and/or metabolically dysregulated hepatic steatosis and can coexist with various hepatic and cardiovascular metabolic diseases.
-
Prof. Pengfei Qiu: Do Breast Cancer Patients with cN1 Who Downstage to ycN0 after Neoadjuvant Therapy and Have Limited SLNB Metastasis Need ALND?
The axillary lymph node burden after neoadjuvant therapy is closely related to prognosis. Unlike the assessment in initial surgery patients, residual tumor cells after neoadjuvant therapy are considered resistant cells. Thus, can limited sentinel lymph node biopsy (SLNB) metastasis after neoadjuvant therapy exempt patients from axillary lymph node dissection (ALND)? At the 2024 South-North Forum,…
-
Professor Yuqian Sun: Advances in Salvage Treatment for Primary Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Graft Failure
Graft failure is a rare but fatal complication following haploidentical allogeneic hematopoietic stem cell transplantation. A second transplant is almost the only salvage measure for transplant failure. However, outcomes from second transplants have generally been poor, as reported in previous literature. The 50th European Society for Blood and Marrow Transplantation (EBMT) annual meeting was held…
-
2024 South-North Forum | Prof. Junjie Li: What’s Next for Neoadjuvant Therapy in HER2-Positive Breast Cancer?
Targeted therapy has always been a critical component of systemic treatment for HER2-positive breast cancer patients. Currently, small-molecule tyrosine kinase inhibitors (TKIs) are commonly used HER2-targeted therapies. What role do TKIs play in the neoadjuvant treatment of HER2-positive breast cancer, and what drug combinations yield the best treatment outcomes? At the 2024 South-North Forum, Prof.…
-
Professor Wenjun Zhang: Focusing on Clinical Application, Key Updates in the 2024 CSCO CAR-T Cell Therapy Guidelines | 2024 CSCO Guidelines Conference
As scheduled, the 2024 China Society of Clinical Oncology (CSCO) guidelines conference has arrived, with many CSCO oncology treatment guidelines being updated or published for the first time. In the field of hematologic oncology, the much-anticipated CAR-T cell therapy guidelines have been significantly updated. The “CSCO CAR-T Cell Therapy for Malignant Hematological Diseases and Management…
-
A Case of Extensive Portal Venous System Thrombosis and Prehepatic Portal Hypertension Following Transition from Low to High Altitude
To broaden the horizons and enrich the practical knowledge of clinical hepatologists, and to cultivate clinical thinking abilities, International Liver Disease has invited Professor Shanhong Tang’s team from the Department of Gastroenterology at Western Theater Command General Hospital to create the “Liver Difficult Cases” column. This column compiles “classic cases” encountered by Professor Tang’s team…
-
Professor Jianming Guo : Enhancing Perioperative Predictive Performance for Kidney Cancer Patients with AI-Assisted Surgical Scoring Systems
Kidney cancer surgical scoring systems provide critical information for treatment planning, surgical method selection, tumor recurrence risk, and patient prognosis. The 39th Annual Congress of the European Association of Urology (EAU24) was held from April 5 to 8, 2024, in Paris, France, where numerous studies and advancements related to kidney cancer surgery were presented. Oncology…
-
Professor Jing Yao: Advancing Clinical Practice with Personalized Treatment Strategies for Breast Cancer Patients丨Jiangcheng Breast Cancer Academic
In early March, as the spring begins in Jiangcheng, the cherry blossoms bloom following the plum blossoms. The 4th Jiangcheng Breast Cancer Academic Forum was successfully held in Wuhan. Experts in breast cancer surgery, medical oncology, radiotherapy, and basic and translational research gathered to present numerous research advancements and clinical development trends. After the conference,…
Connecting Medical Expertise through Media